AstraZeneca holds talks with Bristol Myers Squibb on mega-deal, FT reports

BMY•2026-08-02

AstraZeneca and Bristol Myers Squibb explore combination

Aug. 2 (Reuters) - UK drugmaker AstraZeneca AZN.L has been exploring a deal to combine with U.S. rival Bristol Myers Squibb BMY.N, the Financial Times reported on Sunday, citing people familiar with the matter.

Reuters could not immediately verify the report.

AstraZeneca holds talks with Bristol Myers Squibb on mega-deal, FT reports

AstraZeneca and Bristol Myers Squibb explore combination

Related News

Scripps completes acquisition of WTVQ in Lexington for $15.8 million

The Week in Breakingviews: Wall Street rainstorms

Insight Guru flags uneven rebound odds as Global X Uranium ETF slides 36% from 52-week high

Nasdaq Trade Halt Continues <LTRYW.O> Halt News Pending at 03:28 AM

Bitdeer schedules Q2 2026 earnings call and webcast